Synavant Sells Pharmaceutical DM Unit

Share this content:
The French firm Groupe Cegedim purchased the direct marketing arm of Atlanta-based pharmaceutical marketer Synavant for $43.5 million, the companies said Sunday.

Synavant said it decided that its direct marketing business unit was no longer part of its core business strategy. The DM unit generated $50 million in revenue in the 12 months ending in September 2002.

Proceeds of the sales will be given to shareholders, Synavant said, though the form of the transfer has yet to be decided. Synavant also said it would review its other business units and decide whether to invest more resources in them or consider other transactions.

The purchase expands Groupe Cegedim's presence in North America. Groupe Cegedim also specializes in pharmaceutical marketing.


Next Article in Marketing Strategy

Sign up to our newsletters

Company of the Week

Brightcove is the world's leading video platform. The most innovative and respected brands confidently rely on Brightcove to solve their most demanding communication challenges because of the unmatched performance and flexibility of our platform, our global scale and reliability, and our award-winning service. With thousands of customers and an industry-leading suite of cloud video products, Brightcove enables customers to drive compelling business results.

Find out more here »

Career Center

Check out hundreds of exciting professional opportunities available on DMN's Career Center.  
Explore careers in digital marketing, sales, eCommerce, marketing communications, IT, data strategies, and much more. And don't forget to update your resume so employers can contact you privately about job opportunities.

>>Click Here

Relive the 2017 Marketing Hall of Femme

Click the image above